학술논문
OP-15 - Analysis of the progression-free survival of CLL patients who received first-line bendamustine-rituximab therapy depending on the elimination rate of the minimum residual disease and mutational status IGHV genes
Document Type
Abstract
Author
Source
In Leukemia Research October 2019 85 Supplement 1:S26-S26
Subject
Language
ISSN
0145-2126